Cxcr1 mediates recruitment of neutrophils and supports proliferation of tumor-initiating astrocytes in vivo
- Powell, D., Lou, M., Barros Becker, F., Huttenlocher, A.
- Scientific Reports 8: 13285 (Journal)
- Registered Authors
- Huttenlocher, Anna, Powell, Davalyn
- MeSH Terms
- Cell Movement/physiology
- Cell Proliferation/physiology
- Cell Transformation, Neoplastic/metabolism
- Disease Models, Animal
- Neutrophil Infiltration/immunology
- Neutrophil Infiltration/physiology*
- Receptors, Interleukin-8A/metabolism*
- Signal Transduction
- Tumor Microenvironment
- Zebrafish Proteins/metabolism
- 30185911 Full text @ Sci. Rep.
Powell, D., Lou, M., Barros Becker, F., Huttenlocher, A. (2018) Cxcr1 mediates recruitment of neutrophils and supports proliferation of tumor-initiating astrocytes in vivo. Scientific Reports. 8:13285.
Neutrophils are first-responders to sites of infection and tissue damage including the inflamed tumor microenvironment. Increasing evidence suggests that crosstalk between tumors and neutrophils can affect the progression of established tumors. However, there is a gap in our understanding of the early events that lead to neutrophil recruitment to oncogene-transformed cells and how these pathways alter tumor progression. Here, we use optically transparent zebrafish larvae to probe the early signals that mediate neutrophil recruitment to Kras-transformed astrocytes. We show that zebrafish larvae with impaired neutrophil function exhibit reduced proliferation of transformed astrocytes supporting a critical role for tumor-associated neutrophils in the early progression of tumorigenesis. Moreover, using mutants and pharmacological inhibition, we show that the chemokine receptor Cxcr1 promotes neutrophil recruitment, proliferation of tumor-initiating cells, and neoplastic mass formation. These findings highlight the power of the larval zebrafish system to image and probe early events in the tumor-initiating microenvironment and demonstrate the potential for neutrophil recruitment signaling pathways such as Cxcl8-Cxcr1 as targets for anti-cancer therapies.
Genes / Markers
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Engineered Foreign Genes